Akèy › Amiloidoz ereditè ki gen rapò ak transthyretin › Massachusetts
Etid klinik pou Amiloidoz ereditè ki gen rapò ak transthyretin nan Massachusetts
4 etid pou Amiloidoz ereditè ki gen rapò ak transthyretin ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Boston
- Research Site, Boston
- Research Site, Boston
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 23, 2026 · NCT06465810Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- Massachusetts General Hospital, Boston
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT05577819Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston University (BU) School of Medicine, Boston
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Brigham and Women's Hospital, Boston
- Boston University School of Medicine, Boston
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.